Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gürsel Güneş"'
Autor:
Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen, Mehmet Baysal, Vildan Gürsoy, Esra Yıldızhan, Serkan Güven, Tarık Ercan, Tayfun Elibol, Sinan Mersin, Eylem Genç, Eren Arslan Davulcu, Volkan Karakuş, Nergiz Erkut, Gürsel Güneş, Reyhan Diz Küçükkaya, Ahmet Emre Eşkazan
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 26-36 (2024)
Objective: In this study, we investigated the effects of calreticulin (CALR) and JAK2V617F mutational status on clinical course and disease outcomes in Turkish patients with essential thrombocythemia (ET). Materials and Methods: Seventeen centers fr
Externí odkaz:
https://doaj.org/article/ab5f757b27aa42b59fc159ec0b70c9e6
Autor:
Ümit Yavuz Malkan, Gürsel Güneş, Hakan Göker, İbrahim C. Haznedaroğlu, Kadir Acar, Eylem Eliaçık, Sezgin Etgül, Tuncay Aslan, Seda Balaban, Haluk Demiroğlu, Osman İ. Özcebe, Nilgün Sayınalp, Salih Aksu, Yahya Büyükaşık
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 281-285 (2016)
Objective: Many studies reported an improved prognosis in patients with Burkitt's lymphoma obviating the need of stem cell transplantation. However, prognosis of the advanced disease [i.e. Burkitt's cell leukemia (BCL)] has not been reported with cur
Externí odkaz:
https://doaj.org/article/1c74ba1597b34846a1de542a027b9e28
Autor:
Mehdi Ghasemi, Semih Alpsoy, Seyhan Türk, Ümit Y. Malkan, Şükrü Atakan, İbrahim C. Haznedaroğlu, Gürsel Güneş, Mehmet Gündüz, Burak Yılmaz, Sezgin Etgül, Seda Aydın, Tuncay Aslan, Nilgün Sayınalp, Salih Aksu, Haluk Demiroğlu, Osman İ. Özcebe, Yahya Büyükaşık, Hakan Göker
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 286-292 (2016)
Objective: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battles against the chronic course o
Externí odkaz:
https://doaj.org/article/f4f9f90b278148459d1e22d2fc9074ff
Autor:
Mürüvvet Seda Aydın, Süreyya Bozkurt, Gürsel Güneş, Ümit Yavuz Malkan, Tuncay Aslan, Sezgin Etgül, Yahya Büyükaşık, İbrahim Celalettin Haznedaroğlu, Nilgün Sayınalp, Hakan Göker, Haluk Demiroğlu, Osman İlhami Özcebe, Salih Aksu
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 103-104 (2017)
Externí odkaz:
https://doaj.org/article/94e2e0dcd8d44f589f74300978b465ab
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Hematology Reports, Vol 10, Iss 4 (2018)
Posterior reversible encephalopathy syndrome (PRES) was described in 1996. Herein, we aimed to report an immunosuppression- related PRES case. A 34-year-old woman was diagnosed as t-cell acute lymphoblastic leukemia and allogeneic hematopoietic stem
Externí odkaz:
https://doaj.org/article/e7a95c5813294eeb9dd543f1057f3e2d
Autor:
Seyhan Turk, Umit Yavuz Malkan, Mehdi Ghasemi, Helin Hocaoglu, Duygu Mutlu, Gursel Gunes, Salih Aksu, Ibrahim Celalettin Haznedaroglu
Publikováno v:
SAGE Open Medicine, Vol 5 (2017)
Objective: Ankaferd hemostat is the first topical hemostatic agent about the red blood cell–fibrinogen relations tested in the clinical trials. Ankaferd hemostat consists of standardized plant extracts including Alpinia officinarum, Glycyrrhiza gla
Externí odkaz:
https://doaj.org/article/82fc63041a4f428e91f7d6fc79eac2d1
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Hydroxycarbamide is used in the treatment of essential thrombocytosis and other myeloproliferative disorders. We report the case of a 63-year-old woman with essential thrombocytosis who had melanonychia after the long-term use of the hydroxycarbamide
Externí odkaz:
https://doaj.org/article/f29455492e0a40d39aa0eec2b96b1e3d
Autor:
Gursel Gunes, Haluk Demiroglu, Hakan Goker, Umit Yavuz Malkan, Eylem Eliacik, Okan Yayar, Yahya Buyukasik
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Chronic graft-versus-host disease (cGVHD) is one of the most important causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). Occurring in 30% to 70% of patients, cGVHD has a median time to onset of 4 to 6
Externí odkaz:
https://doaj.org/article/d3d327bb1e894d3f9f7c79a025942c90
Publikováno v:
Case Reports in Medicine, Vol 2015 (2015)
Herein, we aimed to report a diffuse large B cell lymphoma (DLBCL) case that had extensive cutaneous relapse with no skin involvement previously. A 59-year-old man presented to hospital in April 2014 with fatigue, anorexia, fever, and anemia. Cervica
Externí odkaz:
https://doaj.org/article/9d847ea915e246a8b894c47d0a1ded4f